The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Islet autoantibodies can discriminate maturity‐onset diabetes of the young (MODY) from Type 1 diabetes
Open accessAbstract
Diabet. Med. 28, 1028–1033 (2011) Aim Maturity‐onset diabetes of the young is a monogenic form of familial, young‐onset diabetes. It is rare (∼1% diabetes) and may be misdiagnosed as Type 1 diabetes and inappropriately treated with insulin. Type 1 diabetes is characterized by the presence of islet autoantibodies, including glutamate decarboxylase (GAD) and islet antigen‐2 (IA‐2) antibodies. The prevalence of islet autoantibodies is unknown in maturity‐onset diabetes of the young and may have the potential to differentiate this form of diabetes from Type 1 diabetes. The aim of this study was to determine the prevalence of GAD and IA‐2 antibodies in patients with maturity‐onset diabetes of the young and Type 1 diabetes. Methods We measured plasma GAD and IA‐2 antibodies in 508 patients with the most common forms of maturity‐onset diabetes of the young (GCK: n = 227; HNF1A: n = 229; HNF4A: n = 52) and 98 patients with newly diagnosed Type 1 diabetes (diagnosed < 6 months). Autoantibodies were considered positive if ≥ 99th centile of 500 adult control subjects. Results GAD and/or IA‐2 antibodies were present in 80/98 (82%) patients with Type 1 diabetes and 5/508 (< 1%) patients with maturity‐onset diabetes of the young. In the cohort with Type 1 diabetes, both GAD and IA‐2 antibodies were detected in 37.8% of patients, GAD only in 24.5% and IA‐2 only in 19.4%. All five patients with maturity‐onset diabetes of the young with detectable antibodies had GAD antibodies and none had detectable IA‐2 antibodies. Conclusion The prevalence of GAD and IA‐2 antibodies in maturity‐onset diabetes of the young is the same as in control subjects (< 1%). The finding of islet autoantibodies, especially IA‐2 antibodies, makes the diagnosis of maturity‐onset diabetes of the young very unlikely and genetic testing should only be performed if other clinical characteristics strongly suggest this form of diabetes rather than Type 1 diabetes. This supports routine islet autoantibody testing before proceeding to more expensive molecular genetic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationType 1 diabetes associated autoimmunity: natural history, genetic associations and screening
Barker, J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1679 · Cited by 350
Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P. (2008) · Diabetologia · doi:10.1007/s00125-008-0967-2 · Cited by 284
Self-citationGenetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes.
Sabbah, E., Savola, K., Ebeling, T., Kulmala, P., Vähäsalo, P., Ilonen, J., Salmela, P. I., & Knip, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1326 · Cited by 219
Cited by
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Pihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
Self-citationHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
Oram, R. A., Patel, K., Hill, A., Shields, B., McDonald, T. J., Jones, A., Hattersley, A. T., & Weedon, M. N. (2016) · Diabetes Care · doi:10.2337/dc15-1111 · Cited by 349
Self-citationShields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Self-citation
Metadata
- Authors
- McDonald, T. J., Colclough, K., Brown, R., Shields, B., Shepherd, M., Bingley, P., Williams, A., Hattersley, A. T., & Ellard, S.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2011-08-15
- Volume
- 28
- Issue
- 9
- Pages
- 1028-1033
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2129482953
- Cited by
- 229
- References
- 5
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Islet autoantibodies can discriminate maturity‐onset diabetes of the young (MODY) from Type 1 diabetes. https://app.cochat.ai/papers/10.1111/j.1464-5491.2011.03287.x
- The paper
- McDonald, T. J., Colclough, K., Brown, R., Shields, B., Shepherd, M., Bingley, P., Williams, A., Hattersley, A. T., & Ellard, S. (2011). Islet autoantibodies can discriminate maturity‐onset diabetes of the young (MODY) from Type 1 diabetes. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2011.03287.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.